Oriole enables companies that have great new products—or product ideas—to develop and commercialize them. We're focused on OTC meds and animal health products. We advise on clinical development. We provide sales and marketing expertise. We help clients build commercialization infrastructure. We engineer high-value exits.
Oriole enables clients to acquire, license, divest and out-license products. We can lead the deal or provide support services. We help clients find external targets. We assist clients in developing business plans and raising capital.
Formerly CEO of Hubbard / ISA (multinational poultry genetics firm); formerly global head of legal and regulatory affairs at Merial (now part of Boehringer Ingelheim Vetmedica). Previously at Merck. BA, Harvard; J.D.: Penn.
Formerly head of Business Development and Strategy at Merial (company described above). Managed multiple investment decisions in early and late stage animal health technologies. Previously at Merck. B.S., Purdue; MBA South Carolina.